Several companies presented data on their approved and experimental oncology drugs at this year's ASCO meeting, and these biotech stocks look poised for growth.
Arpita Dutt
Advertisement
Articles by Arpita Dutt
Advertisement
Latest Updated Articles
ASCO 2014 Put These Biotech Stocks in FocusPublished: June 4th 2014 | Updated:
Advertisement
Advertisement
Trending on Medical Economics
1
2026 Medicare Physician Fee Schedule: Payment up 2.5% as CMS shifts from ‘sick-care’ to health care
2
2026 Medicare Physician Fee Schedule: A policy ‘grab bag’ that hurts independent practice, telehealth regulations
3
A $40B bet on Tylenol; long-term melatonin use; daily vaping doubles among U.S. teens – Morning Medical Update
4
Preview: Can independent medical practices still succeed? Our expert panel
5
